Metraipolis › archive › dc_4a2da29c831f
Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy — Europe PMC PMID:42797334
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42797334
- DOI
- 10.3390/pharmaceutics18091159
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T13:50:20.801Z
- SHA-256 of the archived text
673610d8d77e991313c7807c580c1152f236e125b940a7e7b85e605b03c1ca24- Stable URL of this page
https://metraipolis.com/documento/dc_4a2da29c831f
How to cite
Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy — Europe PMC PMID:42797334 — Europe PMC (en), https://europepmc.org/article/MED/42797334 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a2da29c831f (Metraipolis archive dc_4a2da29c831f, sha256 673610d8d77e991313c7807c580c1152f236e125b940a7e7b85e605b03c1ca24)
BibTeX
@misc{dc4a2da29c831f,
title = {Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy — Europe PMC PMID:42797334},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42797334},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a2da29c831f; sha256 673610d8d77e991313c7807c580c1152f236e125b940a7e7b85e605b03c1ca24},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797334. Agents can read the archived copy with the MCP tool read_document.